Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,540 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interventions for people with perceptual disorders after stroke: the PIONEER scoping review, Cochrane systematic review and priority setting project.
Hazelton C, Todhunter-Brown A, Campbell P, Thomson K, Nicolson DJ, McGill K, Chung CS, Dorris L, Gillespie DC, Hunter SM, Williams LJ, Brady MC. Hazelton C, et al. Among authors: brady mc. Health Technol Assess. 2024 Oct;28(69):1-141. doi: 10.3310/WGJT3471. Health Technol Assess. 2024. PMID: 39485540 Free PMC article.
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.
Sackley CM, Rick C, Brady MC, Burton C, Jowett S, Patel S, Woolley R, Masterson-Algar P, Nicoll A, Smith CH, Abdali Z, Ives N, Beaton G, Dickson S, Ottridge R, Nankervis H, Clarke CE; PD COMM Collaborative Group. Sackley CM, et al. Among authors: brady mc. Health Technol Assess. 2024 Oct;28(58):1-141. doi: 10.3310/ADWP8001. Health Technol Assess. 2024. PMID: 39364774 Free PMC article. Clinical Trial.
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Lee JM, Brady MF, Miller A, Moore RG, MacKay H, McNally L, Lea J, Street D, Lheureux S, McDonald ME, Duska LR, Cantuaria G, Kavecansky J, Leath CA 3rd, Powell M, Cadungog MG, Rose PG, Kim YM, Huang HQ, Provencher M, Wenzel LB, Bookman MA, Kohn EC, Secord AA. Lee JM, et al. Among authors: brady mf. J Clin Oncol. 2024 Oct 3:JCO2400683. doi: 10.1200/JCO.24.00683. Online ahead of print. J Clin Oncol. 2024. PMID: 39361946
1,540 results